Engineered exosomes delivering specific tumor-suppressive RNAi attenuate oral cancer progression
Yutaro Kase(Chiba University), Hideki Tanzawa(Chiba University Hospital)
Cited by 56
Related Papers
Overexpression of CDCA2 in Human Squamous Cell Carcinoma: Correlation with Prevention of G1 Phase Arrest and Apoptosis
|PLoS ONE|2013|69
Resveratrol Targets Urokinase-Type Plasminogen Activator Receptor Expression to Overcome Cetuximab-Resistance in Oral Squamous Cell Carcinoma
|Scientific Reports|2019|39
Targeting phosphodiesterase 3<scp>B</scp> enhances cisplatin sensitivity in human cancer cells
|Cancer Medicine|2013|27